RHIANNON BAIN: Open Payments
NPI 1215279757 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 43 payments from 13 companies in 2025. Trend: 2023 $825 · 2024 $1,497 · 2025 $848
Food & beverage: $763Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $214 |
| Aimmune Therapeutics, Inc. | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 5 | $86 |
| Janssen Biotech, Inc. | 1 | $85 |
| Ardelyx, Inc. | 4 | $84 |
| PFIZER INC. | 1 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| Madrigal Pharmaceuticals | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: RINVOQ, ZENPEP, DUPIXENT, TREMFYA, IBSRELA, VELSIPITY, XIFAXAN, REZDIFFRA.
Industry payments across TN — which companies pay providers there.
